Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The return on invested capital (ROIC) is -122.21% as of the fiscal period ended Wednesday, December 31, 2025.
Limited history available
MOBI Return on Invested Capital (ROIC) has fewer than three reported periods, so a trend chart would be misleading.
RETURN ON INVESTED CAPITAL (ROIC)
-122.21%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-34.77%
median of 603 covered companies
CURRENT VS SECTOR MEDIAN
-251.48%
vs the sector median at left
Mobia Medical, Inc. Common Stock
Market Cap
$306.56M
Return on Invested Capital (ROIC)
-122.21%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$300.59M
Return on Invested Capital (ROIC)
-28.88%
TTM Avg
-35.80%
3Y Avg
-1011.32%
5Y Avg
-772.02%
Market Cap
$322.98M
Return on Invested Capital (ROIC)
-164.32%
TTM Avg
-159.25%
3Y Avg
-125.06%
5Y Avg
-125.06%
Market Cap
$320.09M
Return on Invested Capital (ROIC)
-35.92%
TTM Avg
-35.67%
3Y Avg
-36.59%
5Y Avg
-30.23%
Market Cap
$320.81M
Return on Invested Capital (ROIC)
-85.56%
TTM Avg
-114.55%
3Y Avg
-77.72%
5Y Avg
-63.50%
Market Cap
$289.60M
Return on Invested Capital (ROIC)
-14.06%
TTM Avg
-26.07%
3Y Avg
-28.37%
5Y Avg
-26.89%
Market Cap
$288.79M
Return on Invested Capital (ROIC)
-61.10%
TTM Avg
-38.45%
3Y Avg
-31.16%
5Y Avg
-81.63%
Market Cap
$286.20M
Return on Invested Capital (ROIC)
-136.49%
TTM Avg
-130.82%
3Y Avg
-85.38%
5Y Avg
-76.42%
Market Cap
$281.41M
Return on Invested Capital (ROIC)
-27.62%
TTM Avg
-16.38%
3Y Avg
-32.77%
5Y Avg
-39.71%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Mobia Medical, Inc. Common Stock (MOBI) | $306.56M | -122.21% | N/A | N/A | N/A |
| Benitec Biopharma Inc. (BNTC)vs › | $300.59M | -28.88% | -35.80% | -1011.32% | -772.02% |
| CapsoVision, Inc. (CV)vs › | $322.98M | -164.32% | -159.25% | -125.06% | -125.06% |
| C4 Therapeutics, Inc. (CCCC)vs › | $320.09M | -35.92% | -35.67% | -36.59% | -30.23% |
| Cabaletta Bio, Inc. (CABA)vs › | $320.81M | -85.56% | -114.55% | -77.72% | -63.50% |
| Standard BioTools Inc. (LAB)vs › | $289.60M | -14.06% | -26.07% | -28.37% | -26.89% |
| BridgeBio Oncology Therapeutics Inc. (BBOT)vs › | $288.79M | -61.10% | -38.45% | -31.16% | -81.63% |
| Larimar Therapeutics, Inc. (LRMR)vs › | $286.20M | -136.49% | -130.82% | -85.38% | -76.42% |
| Fulcrum Therapeutics, Inc. (FULC)vs › | $281.41M | -27.62% | -16.38% | -32.77% | -39.71% |
| ClearPoint Neuro, Inc. (CLPT)vs › | $331.54M | -40.51% | -48.13% | -48.38% | -39.85% |
ROIC
-122.2%
ROE
N/A
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2025-12-31 | -122.21% |
